510(k) device
VITROS BRAHMS PCT Reagent Pack and Calibrators
Ortho Clinical Diagnostics · Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens (PMT, Class II) · First FDA decision Feb 25, 2020, newest Feb 25, 2020Sepsis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "VITROS BRAHMS PCT"
MAUDE reports
0
Brand "VITROS BRAHMS PCT", since 2015
PubMed studies
1
Mentioning "VITROS BRAHMS PCT"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing VITROS BRAHMS PCT Reagent Pack and Calibrators
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K200236 · Decided Feb 25, 2020 · 26 days after receipt
Device type: Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens (PMT) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "VITROS BRAHMS PCT", any status and sponsor, newest update first.
No registered device study names "VITROS BRAHMS PCT".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "VITROS BRAHMS PCT", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PMT
13 reports: 13 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "VITROS BRAHMS PCT"[tiab]. The summary above synthesizes these.
- Analytical evaluation of the novel VITROS BRAHMS procalcitonin immunoassay.
Dupuy AM, Bargnoux AS, Montagnon V, et al. · Scand J Clin Lab Invest · 2020Evaluation Study
Other devices of this type
Also filed under product code PMT.
- Atellica IM BRAHMS Procalcitonin (PCT)Siemens Healthcare Diagnostics, Inc. · 510(k) 2018
- Vidas B.r.a.h.m.s. Pct (Pct)bioMerieux, Inc. · 510(k) 2016
- Elecys BRAHMS PCT, Elecys BRAHMS PCT CalCheck 5Roche Diagnostics · 510(k) 2016
- B.R.A.H.M.S PCT sensitive KRYPTORBrahms GmbH · De Novo 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.